Although decreased tissue sensitivity to insulin is compensated by hyperinsulinemia, IR leads to obesity, hypertension, dyslipidemia, and finally the metabolic syndrome [4]. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.